Steroid injection for osteoarthritis of the hip: A randomized, double‐blind, placebo‐controlled trial

RGW Lambert, EJ Hutchings… - … : Official Journal of …, 2007 - Wiley Online Library
Objective To determine the efficacy of fluoroscopically guided corticosteroid injection for hip
osteoarthritis (OA) in a randomized, double‐blind, placebo‐controlled trial. Methods Fifty‐…

Is treat-to-target really working in rheumatoid arthritis? A longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)

…, HB Hammer, R Dadashova, E Hutchings… - Annals of the …, 2020 - ard.bmj.com
Objectives To investigate whether following a treat-to-target (T2T)-strategy in daily clinical
practice leads to more patients with rheumatoid arthritis (RA) meeting the remission target. …

Adherence to treat-to-target management in rheumatoid arthritis and associated factors: data from the international RA BIODAM cohort

…, J Paschke, R Dadashova, E Hutchings… - The Journal of …, 2020 - jrheum.org
Objective. Compelling evidence supports a treat-to-target (T2T) strategy for optimal outcomes
in rheumatoid arthritis (RA). There is limited knowledge regarding the factors that impede …

Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM

…, HB Hammer, R Dadashova, E Hutchings… - …, 2023 - academic.oup.com
Objectives To investigate whether meticulously following a treat-to-target (T2T)-strategy in
daily clinical practice will lead to less radiographic progression in patients with active RA who …

Comparative pharmacokinetics and pharmacodynamics of two marketed bid formulations of diltiazem in healthy volunteers

…, A Russell, M Raymond, E Hutchings… - … & drug disposition, 1993 - Wiley Online Library
Cardizem®SR and Bi‐Tildiem® were both approved in their respective countries on the basis
of clinical trials demonstrating efficacy and safety in the treatment of angina pectoris. In this …

Outcomes and findings of the international rheumatoid arthritis (RA) BIODAM cohort for validation of soluble biomarkers in RA

…, J Paschke, R Dadashova, E Hutchings… - The Journal of …, 2020 - jrheum.org
Objective. The Outcome Measures in Rheumatology Soluble Biomarker Working Group
initiated an international, multicenter, prospective study, the Rheumatoid Arthritis (RA) BIODAM …

The International RA BIODAM cohort for validation of soluble biomarkers in rheumatoid arthritis: cohort description

…, J Paschke, R Dadashova, E Hutchings… - The Journal of …, 2019 - jrheum.org
Objective The OMERACT Soluble Biomarker Working Group initiated an international,
multicenter, prospective study, The Rheumatoid Arthritis (RA) BIODAM cohort (NCT01476956), to …

POS0111 MORE METICULOUSLY FOLLOWING TREAT-TO-TARGET IN RA DOES NOT LEAD TO LESS RADIOGRAPHIC PROGRESSION: A LONGITUDINAL …

…, HB Hammer, R Dadashova, E Hutchings… - 2022 - ard.bmj.com
Background A Treat-to-Target approach (T2T) is broadly considered to lead to better clinical
outcomes and recommended in patients with RA. However, very few studies have analyzed …

OP0304 metabolomics profiling of human serum for discovering biomarkers to diagnose psoriatic arthritis and ankylosing spondylitis with high specificity

W Han, X Wang, L Li, S Wichuk, E Hutchings… - 2020 - ard.bmj.com
Background: High-specificity biomarkers that can differentiate PsA and AS patients from
healthy people, as well as RA patients, would be extremely helpful for early diagnosis and …

Is treat-to-target really working? A longitudinal analysis in Biodam

…, HB Hammer, R Dadashova, E Hutchings… - Arthritis & …, 2015 - research.regionh.dk
… Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Rana Dadashova, Edna
Hutchings, Joel Paschke, Walter Maksymowych …